28 Leading Point of Care Diagnostics Companies Shaping Innovation and Market Growth Through 2031

Discover the top 28 companies driving innovation in the point of care diagnostics market. This in-depth analysis explores competitive advantages, transformative trends, and key players poised to influence global decentralized diagnostics through 2031. Access the comprehensive market research report here for further insights.

Spotlights on the Industry's Top Point of Care Diagnostics Companies

The global point of care diagnostics market is projected to grow from USD 20.63 billion in 2026 to USD 31.46 billion by 2031, at a CAGR of 8.8% during the forecast period, up from USD 19.38 billion in 2025. The rising prevalence of chronic and infectious diseases worldwide, coupled with an aging population and growing demand for decentralized healthcare, continues to drive adoption of rapid, near-patient testing solutions. Against this backdrop, the following 28 industry leaders stand out for their technical innovations, strategic focus, and pivotal roles in advancing point of care diagnostics globally.

1. Abbott Laboratories

Abbott Laboratories holds a leading position in the point of care diagnostics space with its i-STAT and BinaxNOW platforms, delivering rapid results across cardiac, metabolic, and infectious disease testing. The company's broad installed base and continued investment in digital connectivity strengthen its role in decentralized healthcare delivery worldwide.

2. F. Hoffmann-La Roche Ltd.

Hoffmann-La Roche Ltd. brings deep expertise in molecular and immunoassay technologies to its point of care portfolio, offering platforms that support rapid diagnosis of infectious and chronic conditions. Roche's emphasis on data integration and connectivity helps healthcare providers streamline testing workflows across hospital and community settings.

3. Siemens Healthineers AG

Siemens Healthineers AG distinguishes itself through blood gas, cardiac, and coagulation testing solutions engineered for speed and reliability in critical care environments. Its focus on digital health integration and workflow automation supports hospitals seeking to reduce turnaround times and improve clinical decision-making.

4. QuidelOrtho Corporation

QuidelOrtho Corporation combines rapid immunoassay and molecular testing capabilities to serve a wide range of infectious disease and respiratory diagnostic needs. Formed through the merger of Quidel and Ortho Clinical Diagnostics, the company leverages an expanded portfolio and global distribution network to advance decentralized testing.

5. Danaher

Danaher drives point of care innovation through its diagnostics subsidiaries, supporting hospitals and clinics with automated, connected testing platforms. The company's strategy of targeted acquisitions and sustained R&D investment continues to strengthen its competitive position across multiple diagnostic categories.

6. Becton, Dickinson and Company (BD)

Becton, Dickinson and Company (BD) offers point of care solutions spanning infectious disease detection and specimen management, backed by a strong global service and distribution infrastructure. BD's focus on ease of use and workflow efficiency makes its systems well suited to both hospital and near-patient testing environments.

7. Thermo Fisher Scientific, Inc.

Thermo Fisher Scientific, Inc. supports the point of care diagnostics market with a broad portfolio of rapid testing reagents, instruments, and molecular platforms. The company's scale in life sciences manufacturing and its ongoing investment in assay development strengthen its presence in decentralized and hospital-based testing.

8. bioMérieux

bioMérieux specializes in rapid microbiology and immunoassay diagnostics, with point of care solutions tailored to infectious disease detection and antimicrobial stewardship. Its focus on clinical accuracy and laboratory integration supports healthcare systems aiming to accelerate diagnosis and treatment decisions.

9. EKF Diagnostics

EKF Diagnostics focuses on point of care solutions for diabetes management, hematology, and clinical chemistry, offering compact and reliable devices suited to primary care and decentralized settings. The company's emphasis on affordability and ease of operation appeals to healthcare providers in both established and emerging markets.

10. QIAGEN

QIAGEN brings molecular diagnostics expertise to the point of care segment, offering sample-to-result platforms designed for rapid infectious disease detection. Its continued investment in assay menu expansion and automation supports growing demand for near-patient molecular testing.

11. Werfen S.A.

Werfen S.A. is recognized for its point of care solutions in hemostasis, blood gas, and critical care testing, valued for accuracy and reliability in acute care settings. The company's focus on connectivity and quality management systems supports hospitals seeking consistent, actionable diagnostic data.

12. OraSure Technologies

OraSure Technologies specializes in rapid, easy-to-use diagnostic tests for infectious diseases, with an emphasis on oral fluid and other non-invasive sample collection methods. Its consumer-friendly design philosophy supports expansion into home-based and community testing applications.

13. Trinity Biotech

Trinity Biotech offers point of care diagnostic solutions across infectious disease and diabetes testing, with a portfolio designed for accessibility in both clinical and resource-limited settings. The company's focus on affordability and reliability supports its presence in emerging healthcare markets.

14. Grifols S.A.

Grifols S.A. leverages its plasma and diagnostics expertise to support point of care testing solutions, particularly in transfusion medicine and infectious disease screening. The company's global manufacturing footprint and regulatory experience underpin its role in advancing near-patient diagnostic capabilities.

15. Nova Biomedical

Nova Biomedical is known for its critical care and diabetes point of care analyzers, emphasizing rapid, accurate results for blood gas, electrolyte, and glucose testing. Its focus on instrument reliability and ease of maintenance makes it a preferred choice for hospital and outpatient settings.

16. Sekisui Diagnostics

Sekisui Diagnostics provides rapid diagnostic tests and reagents for infectious disease and coagulation testing, supporting healthcare providers with dependable point of care solutions. The company's manufacturing scale and quality focus strengthen its position across clinical and near-patient testing markets.

17. LifeScan

LifeScan concentrates on blood glucose monitoring solutions, offering point of care and self-testing devices that support diabetes management for patients and healthcare providers alike. Its long-standing brand recognition and focus on user experience continue to drive adoption across decentralized care settings.

18. PTS Diagnostics

PTS Diagnostics delivers compact, easy-to-use point of care analyzers for lipid panels, HbA1c, and related metabolic testing, designed for use in primary care and wellness settings. The company's emphasis on portability and rapid results supports preventive health and chronic disease management initiatives.

19. Eurolyser Diagnostica GmbH

Eurolyser Diagnostica GmbH offers a range of point of care analyzers for clinical chemistry, hematology, and infection markers, tailored to the needs of primary care practices. Its focus on compact instrument design and straightforward operation supports adoption across European and international decentralized care networks.

20. Response Biomedical

Response Biomedical specializes in rapid, quantitative point of care testing for cardiac and infectious disease markers, supporting timely clinical decision-making in emergency and critical care environments. Its technology platform emphasizes accuracy comparable to central laboratory methods within a near-patient format.

21. Alfa Scientific Designs, Inc.

Alfa Scientific Designs, Inc. develops rapid lateral flow diagnostic tests for infectious disease and drugs-of-abuse screening, serving clinical, workplace, and community testing needs. The company's manufacturing flexibility and broad test menu support its role in accessible, affordable point of care testing.

22. BTNX Inc.

BTNX Inc. focuses on rapid lateral flow test development for infectious disease and toxicology applications, with manufacturing capabilities that support large-scale distribution. Its agility in responding to emerging testing needs has strengthened its position in the point of care diagnostics landscape.

23. Ascensia Diabetes Care Holdings AG

Ascensia Diabetes Care Holdings AG concentrates on blood glucose monitoring systems, combining connected devices with digital health tools to support diabetes management. The company's continued investment in sensor accuracy and mobile integration reflects the broader shift toward connected point of care solutions.

24. Fluxergy

Fluxergy develops compact molecular diagnostic platforms designed to bring PCR-level accuracy to the point of care setting. Its emphasis on rapid, multiplexed testing positions the company to address growing demand for decentralized infectious disease diagnostics.

25. Precision Biosensor, Inc.

Precision Biosensor, Inc. specializes in fluorescence immunoassay-based point of care analyzers for cardiac, infectious disease, and inflammation biomarkers. The company's focus on quantitative accuracy and compact instrument design supports its expansion across hospital and primary care markets.

26. ACON Laboratories, Inc.

ACON Laboratories, Inc. offers a broad portfolio of rapid diagnostic tests spanning infectious disease, pregnancy, and drugs-of-abuse screening, supported by extensive global manufacturing capacity. Its scale and diversified product range make it a significant supplier to both clinical and consumer testing channels.

27. Menarini Diagnostics S.r.l.

Menarini Diagnostics S.r.l. provides point of care solutions for diabetes and hematology testing, with strong presence across European healthcare systems. The company's focus on regulatory compliance and clinical validation supports its position in both routine and specialized near-patient diagnostics.

28. Mankind Pharma

Mankind Pharma has expanded into point of care diagnostics as part of its broader healthcare portfolio, targeting rapid and affordable testing solutions for infectious disease and chronic condition management. Its extensive domestic distribution network positions the company to advance decentralized diagnostic access across emerging markets.